The national and provincial prevalence and non-fatal burdens of diabetes in China from 2005 to 2023 with projections of prevalence to 2050
The health burden and economic cost associated with diabetes are profound. There is an urgent need to scale up preventive efforts and improve population awareness to enhance disease management and achieve optimal treatment outcomes.
Authors
- Marie Ng (ORCID: https://orcid.org/0000-0001-8243-4096)
- Jiang-Mei Liu
- Maigeng Zhou (ORCID: https://orcid.org/0000-0002-1046-6803)
- Zhenping Zhao (ORCID: https://orcid.org/0000-0003-4227-3034)
Institutions
- Shandong University (CN)
- National University of Singapore (SG)
- National Center for Chronic and Noncommunicable Disease Control and Prevention (CN)
Publication Details
- Journal
- Military Medical Research
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1186/s40779-025-00615-1
- Citations
- 33
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 42.73
Funders
- Key Technologies Research and Development Program
- National Key Research and Development Program of China